SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...
Timing is critical in diagnosing diseases such as cancer. Researchers within The Grainger College of Engineering at the ...
Morning Overview on MSN
Photonics and nanotech may detect cancer signals 5 to 8 years early
Scientists working at the intersection of photonics and nanotechnology are building tools that could identify cancer-related signals in blood samples collected five to eight years before a clinical ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients. The cobas EGFR Mutation Test v2 is a ...
NEW YORK, NY, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- Liv Hospital today launched an informative guide to ...
Does surgical smoke spread bladder cancer during RARC? New research finds no cancer cells or DNA present. Learn more about ...
State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results